Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer
- 1 November 2006
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 66 (3), 654-662
- https://doi.org/10.1016/j.ijrobp.2006.05.037
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Spread of Prostate Carcinoma to the Perirectal Lymph Node BasinThe American Journal of Surgical Pathology, 2004
- Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trialUrologic Oncology: Seminars and Original Investigations, 2003
- Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413Journal of Clinical Oncology, 2003
- Extended Pelvic Lymphadenectomy In Patients Undergoing Radical Prostatectomy: High Incidence Of Lymph Node MetastasisJournal of Urology, 2002
- Dose/Volume Relationship of Late Rectal Bleeding After External Beam Radiotherapy for Localized Prostate CancerThe Cancer Journal, 2002
- Internal organ motion in prostate cancer patients treated in prone and supine treatment positionRadiotherapy and Oncology, 1999
- Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994